Abrdn Life Sciences Investors (HQL)

HQL Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec 23, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	511	448	412	343	505	413
Market Cap Growth	-	8.58%	20.08%	-31.99%	22.27%	20.21%
Enterprise Value	511	448	422	352	505	413
Last Close Price	17.25	15.05	12.79	9.38	13.07	10.17
PE Ratio	5.97	5.23	4.84	-	7.83	3.36
PS Ratio	263.40	231.02	103.63	113.77	220.89	121.78
PB Ratio	0.99	0.87	0.90	0.86	0.97	0.85
P/TBV Ratio	0.99	0.87	0.90	0.86	0.97	0.85
P/OCF Ratio	16.10	14.12	-	-	-	-
EV/Sales Ratio	263.36	231.02	105.98	116.55	220.89	121.78
Debt / Equity Ratio	-	-	-	0.03	0.02	0
Asset Turnover	0.00	0.00	-	0.01	0.00	0.01
Quick Ratio	0.71	0.71	0.27	0.04	0.01	0.28
Current Ratio	0.73	0.73	0.32	0.70	0.80	8.88
Return on Equity (ROE)	17.59%	17.59%	-	-22.71%	12.82%	28.38%
Return on Assets (ROA)	-0.43%	-0.43%	-	-0.39%	-0.51%	-0.30%
Return on Capital (ROIC)	-0.43%	-0.43%	-	-0.40%	-0.51%	-0.30%
Return on Capital Employed (ROCE)	-0.70%	-0.70%	-0.40%	-0.80%	-0.80%	-0.40%
Earnings Yield	16.76%	19.11%	20.68%	-30.45%	12.78%	29.79%
Dividend Yield	10.55%	12.09%	12.97%	15.67%	12.78%	14.45%
Payout Ratio	62.94%	36.96%	-	-	-	-
Buyback Yield / Dilution	-5.48%	-5.48%	-9.28%	-4.10%	-3.29%	-3.03%
Total Shareholder Return	5.17%	6.62%	3.70%	11.57%	9.49%	11.42%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q